PLAUR and neoplasm: Indeed, the substitution of Ser90 in full length, membrane-associated uPAR with a glutamic acid residue prevents the complex uPAR/FPR1/vitronectin receptor cross-talk, thereby blocking tumour cell migration and invasion in vitro and in vivo [23].